Moreover, the increase of blood selenium and selenoproteins in NAFLD mice model attenuated inflammation, lipogenesis, dysfunction of lipid metabolism, and oxidative stress, retarded progression of simple steatosis to NASH, even liver fibrosis and cirrhosis [46]. The gene discussed is SELENOS; the disease is metabolic dysfunction-associated steatotic liver disease.